Genome-Based Therapeutics Targeted Drug Discovery and Development

Status

Published

on 18 Dec 2012

Year of Creation

2012

THE NATIONAL ACADEMIES

Registration Number

TX0007669158

on 18 Dec 2012

The U.S. Copyright record (Registration Number: TX0007669158) dated 18 Dec 2012, pertains to an electronic file (eService) titled "Genome-Based Therapeutics Targeted Drug Discovery and Development" created in 2012. The copyright holder is THE NATIONAL ACADEMIES, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to THE NATIONAL ACADEMIES.

THE NATIONAL ACADEMIES

Application Details

Registration Number

TX0007669158

Registration Date

12/18/2012

Year of Creation

2012

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

NATIONAL ACADEMIES

Physical Description

Book, 89 p

First Publication Nation

United States

ISBN

9780309260244

Corporate Authors

NATIONAL ACADEMIES

Notes

Rights Note: BARBARA MURPHY, THE NATIONAL ACADEMIES, 500 FIFTH STREET NW, KECK 358, WASHINGTON, DC, 20001, United States, (202) 334-1902, bmurphy@nas.edu

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Genome-Based Therapeutics Targeted Drug Discovery and Development

Author Statement: THE NATIONAL ACADEMIES employer for hire Domicile: United States Citizenship: United States Authorship: text, editing, artwork

Notes

Rights Note: BARBARA MURPHY, THE NATIONAL ACADEMIES, 500 FIFTH STREET NW, KECK 358, WASHINGTON, DC, 20001, United States, (202) 334-1902, bmurphy@nas.edu

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Genome-Based Therapeutics Targeted Drug Discovery and Development

Author Statement: THE NATIONAL ACADEMIES employer for hire Domicile: United States Citizenship: United States Authorship: text, editing, artwork

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.